| 2016-03 |
A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach |
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
|
| 2016-02 |
A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis |
RADIOTHERAPY AND ONCOLOGY
|
| 2016-01 |
p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer |
CANCER RESEARCH AND TREATMENT
|
| 2015-12 |
A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
| 2015-10 |
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine |
CANCER RESEARCH AND TREATMENT
|
| 2015-05 |
Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer |
ANNALS OF SURGICAL ONCOLOGY
|
| 2015-05 |
PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity |
INTERNATIONAL JOURNAL OF CANCER
|
| 2015-04 |
Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases |
CANCER RESEARCH AND TREATMENT
|
| 2015-03 |
Clinical Implications from a Single-Center Study of Colorectal Adenocarcinoma in Transplant Recipients |
ONCOLOGY
|
| 2015-01 |
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children |
CANCER RESEARCH AND TREATMENT
|
| 2014-08 |
Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. |
JOURNAL OF SURGICAL ONCOLOGY
|
| 2014-07 |
High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients |
WORLD JOURNAL OF SURGICAL ONCOLOGY
|
| 2014-06 |
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer |
INVESTIGATIONAL NEW DRUGS
|
| 2014-04 |
Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus |
ANTICANCER RESEARCH
|
| 2014-03 |
Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2013-10 |
Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study |
ANNALS OF SURGICAL ONCOLOGY
|
| 2013-10 |
Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2013-10 |
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2013-09 |
Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater |
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
|
| 2013-09 |
Changing treatment patterns in elderly patients with resectable colon cancer |
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
|
| 2013-06 |
Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications |
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
|
| 2013-06 |
Combination of CYP Inhibitor with MEK/ERK Inhibitor Enhances the Inhibitory Effect on ERK in BRAF Mutant Colon Cancer Cells |
ANTICANCER RESEARCH
|
| 2013-06 |
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors |
SUPPORTIVE CARE IN CANCER
|
| 2013-05 |
Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study |
JOURNAL OF SURGICAL ONCOLOGY
|
| 2013-02 |
Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent |
INVESTIGATIONAL NEW DRUGS
|
| 2013-01 |
Quantitation and pharmacokinetics of 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) in rat plasma by liquid chromatography-tandem mass spectrometry |
JOURNAL OF SEPARATION SCIENCE
|
| 2013-01 |
The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients |
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
|
| 2012-12 |
Quantitative Analysis of ERK Signaling Inhibition in Colon Cancer Cell Lines Using Phospho-Specific Flow Cytometry |
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
|
| 2012-10 |
Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience |
BMC CANCER
|
| 2012-10 |
VIPoma that arose from the rectum in a 65-year-old male patient |
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
|
| 2012-10 |
Response Evaluation in Patients With Colorectal Liver Metastases:RECIST Version 1.1 Versus Modified CT Criteria |
AMERICAN JOURNAL OF ROENTGENOLOGY
|
| 2012-09 |
Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer |
SURGICAL ONCOLOGY-OXFORD
|
| 2012-08 |
A phase i pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy |
INVESTIGATIONAL NEW DRUGS
|
| 2012-08 |
Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer |
EUROPEAN RADIOLOGY
|
| 2012-06 |
Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea |
CLINICAL THERAPEUTICS
|
| 2012-04 |
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy |
INVESTIGATIONAL NEW DRUGS
|
| 2012-03 |
Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience |
YONSEI MEDICAL JOURNAL
|
| 2012-03 |
Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis |
Cancer Research and Treatment
|
| 2012-03 |
Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging |
JOURNAL OF MAGNETIC RESONANCE IMAGING
|
| 2012-01 |
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2012-01 |
Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis |
BRITISH JOURNAL OF CANCER
|
| 2011-11 |
Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
| 2011-10 |
Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer |
INVESTIGATIONAL NEW DRUGS
|
| 2011-09 |
Comparison of Diffusion-Weighted MRI and MR Volumetry in the Evaluation of Early Treatment Outcomes After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer |
JOURNAL OF MAGNETIC RESONANCE IMAGING
|
| 2011-09 |
Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer |
ANTI-CANCER DRUGS
|
| 2011-08 |
Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases |
RADIATION ONCOLOGY
|
| 2011-05 |
DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer |
CANCER
|
| 2011-05 |
A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy |
CANCER
|
| 2011-01 |
Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis |
ONCOLOGY
|
| 2011-01 |
Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2011-01 |
Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity |
ONCOLOGY
|
| 2011-01 |
Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles |
ONCOLOGY
|
| 2011-01 |
Brain metastases from colorectal carcinoma: prognostic factors and outcome |
JOURNAL OF NEURO-ONCOLOGY
|
| 2010-12 |
A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy |
Cancer Research and Treatment
|
| 2010-10 |
Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial |
Lung Cancer
|
| 2010-08 |
The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study |
RADIATION ONCOLOGY
|
| 2010-07 |
A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer |
Investigational New Drugs
|
| 2010-06 |
Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer |
Radiotherapy And Oncology
|
| 2010-03 |
Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2010-02 |
A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer |
American Journal of Clinical Oncology-Cancer Clinical Trials
|
| 2010-02 |
Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients |
Cancer Letters
|
| 2010-01 |
Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 2009-12 |
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2009-06 |
Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in korea |
Cancer Research And Treatment
|
| 2009-04 |
Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction |
Yonsei Medical Journal
|
| 2009-04 |
Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2009-03 |
Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer |
International Journal Of Oncology
|
| 2009-02 |
Brain metastases from hepatocellular carcinoma: prognostic factors and outcome |
Journal Of Neuro-Oncology
|
| 2008-11 |
Mobilized CD34(+) cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer |
Cancer Letters
|
| 2008-06 |
The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC |
Lung Cancer
|
| 2008-02 |
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer |
Annals Of Oncology
|
| 2008-01 |
Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy |
Cancer Chemotherapy And Pharmacology
|
| 2008-01 |
The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer |
Cancer Chemotherapy And Pharmacology
|
| 2008-01 |
Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer |
Cancer Chemotherapy And Pharmacology
|
| 2008-01 |
Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer |
Radiotherapy And Oncology
|